Hutch News

Hutch News

Stories tagged 'Pediatric Oncology'

Big data in cancer research

New study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets

Dec. 21, 2017 | By Susan Keown / Fred Hutch News Service

Big data is the new reality in cancer research, yielding powerful insights into disease biology — as a recent study in pediatric leukemia showed. But how to store, share or even make sense of such vasts amounts of information?

View story >


‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment

Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’

Dec. 11, 2017 | By Susan Keown / Fred Hutch News Service

Researchers found key differences between the molecular signatures of AML in patients of different ages: So why should we keep assuming that therapies developed for the elderly will work for the young?

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.